Olink Proteomics
Olink Proteomics's Overview
Olink Proteomics is a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. Olink provides a platform of products and services which are deployed with customers globally for human protein biomarker discovery, leveraging its proprietary Proximity Extension Assay (PEA) technology. The company was acquired by Thermo Fisher Scientific in February 2024 and is being integrated into Thermo Fisher’s Life Sciences Solutions Segment.
Where is Olink Proteomics's Headquarters?
HQ Function
Global operational hub, driving research and development, manufacturing of proteomic kits, and overseeing worldwide corporate strategy.
Notable Features:
Situated within the Uppsala Science Park, a vibrant ecosystem fostering collaboration between academia and industry in life sciences. The facilities are modern and designed to support cutting-edge proteomic research and production.
Work Culture:
A dynamic and innovative environment focused on scientific excellence, collaboration, and a commitment to advancing proteomics. Employees are driven by the mission to impact human health through biomarker discovery.
HQ Significance:
Uppsala's rich history as a center for life sciences in Sweden makes it a strategic location. The HQ's proximity to Uppsala University and other biotech companies facilitates talent acquisition and research partnerships.
Values Reflected in HQ: The HQ's focus on state-of-the-art labs and collaborative spaces reflects Olink's core values of innovation, quality, and scientific rigor in advancing proteomics.
Location:
Olink Proteomics supports researchers and clinicians globally through its direct sales and support teams, certified service laboratories, and distribution partners. Key operational regions include North America, Europe (including the Nordics and UK), and Asia-Pacific (including China, Japan, Singapore, and Australia). This widespread presence enables Olink to provide its advanced proteomic solutions and support to a diverse range of customers in academic, pharmaceutical, and clinical settings worldwide.
Street Address:
Dag Hammarskjölds väg 52B
City:
Uppsala
State/Province:
Uppsala County
Country:
Sweden
Olink Proteomics's Global Presence
Watertown, MA, USA
Address: 100 Forge, 480 Arsenal Street, Suite 110, Watertown, MA 02472, USA
To serve the significant North American market, including pharmaceutical companies, academic research institutions, and clinical laboratories.
Shanghai, China
Address: Unit 101, Building 1, Lane 555, Puhui Road, Minhang District, Shanghai, China
To expand Olink's presence and support the growing demand for proteomics solutions in China and the broader APAC market.
Tokyo, Japan
Address: PMO Hamamatsucho II, 2-7-1 Hamamatsu-cho, Minato-ku, Tokyo 105-0013, Japan
To cater specifically to the advanced Japanese life sciences and healthcare research sector, fostering collaborations and driving adoption of Olink's technology.
Leiden, Netherlands
Address: BioPartner 5 building, De Limes 7, 2342 DH Oegstgeest (postal address) / Niels Bohrweg 11-13, 2333 CA Leiden (visiting address), Netherlands
To provide accessible services and support to Olink's European customer base, facilitating research and clinical applications across the continent.
Buying Intent Signals for Olink Proteomics
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Olink Proteomics
As of April 2025, Olink Proteomics' leadership includes:
Investors of Olink Proteomics
Olink Proteomics has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
The most significant development impacting Olink's executive structure in the last 12-18 months is its acquisition by Thermo Fisher Scientific, completed in February 2024. This has initiated a process of integrating Olink's leadership into Thermo Fisher's Life Sciences Solutions Segment. Prior to this, Olink made strategic appointments to strengthen its commercial operations. For instance, Mary D. Reumuth was appointed SVP, Commercial Operations Americas in March 2023.
New Appointments:
Technology (Tech Stack) used by Olink Proteomics
Discover the tools Olink Proteomics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Olink Proteomics Email Formats and Examples
Olink Proteomics commonly uses the 'firstname.lastname@olink.com' email format. Variations might exist, but this is a widely observed pattern.
firstname.lastname@olink.com
Format
jane.doe@olink.com
Example
85%
Success rate
News and media
Thermo Fisher Scientific Press Release • February 6, 2024
Olink Proteomics News: Thermo Fisher Scientific Completes Acquisition of Olink Holding AB (publ)
Thermo Fisher Scientific Inc. today announced that it has completed its acquisition of Olink Holding AB (publ), a leading provider of next-generation proteomics solutions. Olink will be integrated into Thermo Fisher’s Life Sciences Solutions Segment....more
Olink Proteomics Press Release (via GlobeNewswire) • October 17, 2023
Olink Proteomics News: Olink and Thermo Fisher Scientific Announce Definitive Agreement for Thermo Fisher to Acquire Olink
Olink Holding AB (publ) and Thermo Fisher Scientific Inc. announced that their respective boards of directors have approved a definitive agreement under which Thermo Fisher will acquire Olink for $26.00 per common share in cash, representing a transaction value of approximately $3.1 billion....more
Olink Proteomics Press Release (via GlobeNewswire) • January 9, 2024
Olink Proteomics News: Olink Provides Preliminary Unaudited Full Year and Fourth Quarter 2023 Revenue
Olink reported preliminary unaudited revenue for the full year 2023 of approximately $169.6 million, representing about 20% reported growth compared to full year 2022. Preliminary unaudited revenue for the fourth quarter 2023 was approximately $66.0 million, up about 25% reported....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Olink Proteomics, are just a search away.